ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

Ann Med Res. 1998; 5(2): 110-113


THE HİSTOPATHOLOGİCINVESTİGATİON OF THE OTOTOXİC EFFECTS OF CİSPLATİNUMAND CİSPLATİN-GENTAMYCİN ON GUİNEA PİGS.

 

Dr. Azi z ÖZTÜRK*, Dr . Enver ALTAŞ*, Dr. Bülent AKTAN*,  Dr . Soner ÖZER*, Dr. R Murat KARAŞEN*,  Dr . Aki f ÇİFTÇİOĞLU**

.



Abstract
Download PDF Post


 

A wide ranged different drugs have been proved to be ototoxic in the last 50 years. These are aminoglycosides, loop diuretics, local anesthetics, anti neoplastic drugs and non-steroidal anti-inflammatory agents. In this study, probable ototoxic side effects of cisplatin, anti neoplastic agent, with or without gentamyci n on the guinea pig's cochlea was evaluated light microscopically. Finally, it was found that nucleer loss and degeneration of hair cells in the bazal turn of cochlea as well the changes in spiral ganglion and nerve fibers.

These degenerative changes were more severe in the group IV which on cisplatin and gentamycin combination as compared with group III which on cisplatin only. Thus, it was found that cisplatin and gentamycin combination may be more ototoxic that the use of only cisplatin. For statistically analysis, Wilcoxon Signed-Rank test was used. Cisplatin group (group III) was compared cisplatin-gentamycin group (group IV) and was statistically signif cant (p





Bibliomed Article Statistics

29
21
32
32
32
28
35
21
24
13
17
11
R
E
A
D
S

20

8

9

14

8

6

11

7

12

10

13

11
D
O
W
N
L
O
A
D
S
010203040506070809101112
2025

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.